FDA.reportPublic FDA data

tremelimumab-actl 20 MG/ML per 15 ML Injection

RxCUI
2619317
RxNorm name
tremelimumab-actl 20 MG/ML per 15 ML Injection
Display name
tremelimumab-actl 20 MG/ML per 15 ML Injection
Full name
tremelimumab-actl 20 MG/ML per 15 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761289Imjudotremelimumab-actl351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
IMJUDOTREMELIMUMABAstraZeneca Pharmaceuticals LP6690679c-be2f-4588-a2e4-89fff74dd6be2024-07-24Warnings, Adverse reactionsExact identifier
rxcui: 2619317

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6690679c-be2f-4588-a2e4-89fff74dd6betremelimumab-actl 300 MG in 15 ML Injection [PSN] · 15 ML tremelimumab-actl 20 MG/ML Injection [SCD] · tremelimumab-actl 20 MG/ML per 15 ML Injection [SY] · tremelimumab-actl 300 MG per 15 ML Injection [SY]414These highlights do not include all the information needed to use IMJUDO safely and effectively. See full prescribing information for IMJUDO. IMJUDO ® (tremelimumab-actl) injection, for intravenous use Initial U.S. Approval: 202220240724